Диссертация (1141097), страница 18
Текст из файла (страница 18)
Ciavattini, J. Di Giuseppe,P. Stortoni, N. Montik et al. // Obstet. Gynecol. Int. – 2013; 2013: 173184.doi: 10.1155/2013/173184. Epub. 2013. – Sep. 12.121.Tokyol, C. Expression of vascular endothelial growth factor and matrixmetalloproteinase-2 in uterine leiomyoma and correlation with angiogenesis /112C. Tokyol, F. Aktepe, F.H. Dilek, M. Yilmazer // S.D.U.
Tip Fak. Derg. – 2011. –Vol. 18 (3). – P. 86-91.122.Commandeur, A.E. Epidemiological and genetic clues for molecularmechanisms involved in uterine leiomyoma development and growth /A.E. Commandeur, A.K. Styer, J.M. Teixeira // Hum. Reprod. Update. – 2015. –Sep. – Vol. 21 (5) – P. 593-615.123.Cook, H. The impact of uterine leiomyomas on reproductive outcomes /H. Cook, M. Ezzati, J.H.
Segars, K. McCarthy // Minerva Ginecol. – 2010. – Jun.– Vol. 62 (3). – P. 225-236.124.Creus, M. The effect of different hormone therapies on integrin expressionand pinopode formation in the human endometrium: a controlled study /M. Creus, J. Ordi, F. Fabregues et al. // Hum. Reprod. – Apr. – 2003. –Vol. 18(4). – P. 683-693.125.Dimitriadis, E. Local regulation of implantation at the human fetal-maternal interface / E. Dimitriadis, G. Nie // Int. J.
Dev. Biol. – 2010. – Vol. 54. –P. 313-322.126.Discepola, F. Analysis of arterial blood vessels surrounding the myoma:relevance to myomectomy / F. Discepola, D.A. Valenti, C. Reinhold, T. Tulandi// Obstet. Gynecol. – 2007. – Dec. – Vol. 110 (6).
– P. 1301-1303.127.Dixon, D. Cell proliferation and apoptosis in human uterine leiomyomasand myometria / D. Dixon, G.P. Flacke, A.B. Moore et al. // Virchows Arch. –2002. – Vol. 441. – № 1. – P. 53-62.128.Duhan, N. Current and emerging treatments for uterine myoma – an update/ N. Duhan // Int. J. Womens Health. – 2011. – Vol. 3.
– P. 231-241.129.Edgell, T.A. Assessing receptivity in the endometrium: the need for a rapid,non-invasive test / T.A. Edgell, L.J. Rombauts, L.A. Salamonsen // Reprod.Biomed. Online. – 2013. – Vol. 27 (5). – P. 486-496.130.Egli, M. Prolactin secretion patterns: basic mechanisms and clinicalimplications for reproduction / M. Egli, B. Leeners, T.H. Kruger // Reproduction.– 2010. – Vol. 140. – P. 643-654.113131.Engman, M. Mifepristone for treatment of uterine leiomyoma. Aprospective randomized placebo controlled trial / M.
Engman, S. Granberg,A.R. Williams, C.X. Meng et al. // Hum. Reprod. – 2009. – Aug. – Vol. 24 (8). –P. 1870-1879.132.Engman, M. GSTM1 gene expression correlates to leiomyoma volumeregression in response to mifepristone treatment / M. Engman, S. Varghese,R.K. Lagerstedt, H. Malmgren et al.
// PLoS One. – 2013. – Dec. – Vol. 8 (12):e80114. doi: 10.1371/journal.pone.0080114. eCollection – 2013.133.Ernest Hung Yu, N.G. Ultrasound assessment of endometrial receptivity inin vitro fertilization treatment / Ernest Hung Yu N.G., Pak Chung H.O. // DonaldSchool Journal of Ultrasound in Obstetrics and Gynecology. – 2010. – April-June– Vol.
4 (2). – P. 179-188.134.Fagherazzi, S. Pregnancy outcome after laparoscopic myomectomy /S. Fagherazzi, S. Borgato, M. Bertin, A. Vitagliano et al. // Clin. Exp. Obstet.Gynecol. – 2014. – Vol. 41 (4). – P. 375-379.135.Fatemi, H.M. Implantation in assisted reproduction: a look at endometrialreceptivity / H.M. Fatemi, B. Popovic-Todorovic // Reprod. Biomed.
Online. –2013. – Vol. 27 (5). – P. 530-538.136.Fernandez, H. Uterine fibroids / H. Fernandez // Rev. Prat. – 2014. – Apr. –Vol. 64 (4). – P. 540-544.137.Fiscella, J. Distinguishing features of endometrial pathology after exposureto the progesterone receptor modulator mifepristone / J. Fiscella, T. Bonfiglio,P.
Winters, S.H. Eisinger, K. Fiscella // Hum. Pathol. – 2011. – Jul. – Vol. 42 (7).– P. 947-953.138.Flake, G.P. Etiology and pathogenesis of uterine leiomyomas: a review /G.P. Flake, J. Andersen, D. Dixon // Environmental Health Perspectives – 2003.– Vol. 111. – № 8. – P. 1037-1054.139.Fleischer, R. Pathophysiology of fibroid disease: angiogenesis andregulation of smooth muscle proliferation / R. Fleischer, G.C. Weston,114B.J. Vollenhoven, P.A.
Rogers // Best Pract. Res. Clin. Obstet. Gynaecol. – 2008.– Aug. – Vol. 22 (4). – P. 603-614.140.Galvao, A.M. Cytokines and angiogenesis in the corpus luteum /A.M. Galvao, G. Ferreira-Dias, D.J. Skarzynski // Mediators. Inflamm. – 2013;2013: 420186. doi: 10.1155/2013/420186. Epub. – 2013. – Jun 11.141.Garcia, L.,Isaacson K.Utero-ovarianvesselafteruterinearteryembolization / L. Garcia, K. Isaacson // J. Minim. Invasive. Gynecol. – 2012. –Jan-Feb.
– Vol. 19 (1). – P. 12.142.Gargiulo, A.R.Detectionofimplantation-relatedcytokinesincervicovaginal secretions and peripheral blood of fertile women during ovulatorymenstrual cycles / A.R. Gargiulo, R.N. Fichorova, J.A. Politch, J.A. Hill,D.J. Anderson // Fertil. Steril. – 2004. – Vol. 82. – Suppl. 3. – P. 1226-1234.143.Guo, X.C. The impact and management of fibroids for fertility: anevidence-based approach / X.C. Guo, J.H.
Segars // Obstet. Gynecol. Clin. North.Am. – 2012. – Dec. – Vol. 39 (4). – P. 521-533.144.Gupta, J.K. Uterine artery embolization for symptomatic uterine fibroids /J.K. Gupta, A. Sinha, M. Lumsden, M. Hickey // Cochrane Database Syst. Rev. –2014. – 26 Dec; 12: CD005073. doi: 10.1002/14651858.CD005073.pub4.145.Hackethal, A. Laparoscopic myomectomy in patients with uterine myomasassociated with infertility / A. Hackethal, A. Westermann, G. Tchartchian,F.
Oehmke, H.R. Tinneberg et al. // Minim. Invasive Ther. Allied. Technol. –2011. – Dec. – Vol. 20 (6). – P. 338-345.146.Hammoda, M.A.AssessmentofLeukemiainhibitoryfactorandglycoprotein g 130 expression in endometrium and uterine flushing: a possiblediagnostic tool for impaired fertility / M.A. Hammoda, M.A. Eid // BMCWomen’s health.
– 2012. – Vol. 12. – P. 10.147.Haouzi, D. Identification of new biomarkers of human endometrialreceptivity in the natural cycle / D. Haouzi, K. Mahmoud // Hum. Reprod. –2009. – Vol. 24 (1). – P. 198-205.115148.Hasegawa, E. Expression of leukemia inhibitory factor in the endometriumin abnormal uterine cavities during the implantation window / E.
Hasegawa,H. Ito, F. Hasegawa, K. Hatano et al. // Fertil. Steril. – 2012. – Vol. 97 (4). –P. 953-958.149.Hee, H.J. Contemporary management of fibroids in rregnancy / H.J. Hee,E.R. Norwitz, J. Shaw // Rev. Obstet. Gynecol. – 2010. – Vol. 3 (1). – P. 20-27.150.Heertum, K.V. Uterine fibroids associated with infertility / K.V.
Heertum,L. Barmat // Womens Health (Lond Engl). – 2014. – Nov. – Vol. 10 (6). – P. 645653.151.Hodge, J.C. Uterine leiomyomata and decreased height: a commonHMGA2 predisposition allele / J.C. Hodge, K.T. Cuenco, K.L. Huyck et al. //Human Genetics. – 2009. – Vol. 125 (3). – P. 257-263.152.Homer, H. Uterine artery embolization for fibroids is associated with anincreased risk of miscarriage / H. Homer, E. Saridogan // Fertil.
Steril. – 2010. –Vol. 94 (1). – P. 324-330.153.Horcajadas, J.A. Endometrial receptivity and implantation are not affectedby the presence of uterine intramural leiomyomas: a clinical and functionalgenomics analysis / J.A. Horcajadas, E. Goyri, M.A. Higon et al. // The Journal ofclinical endocrinology and metabolism. – Sep. – 2008. – Vol. 93(9). – P. 34903498.154.Horne, A.W.
The effect of uterine fibroids on embryo implantation /A.W. Horne, H.O. Critchley // Seminars in reproductive medicine. – Nov. – 2007.– Vol. 25 (6). – P. 483-489.155.Hrubosova, E. Uterine fibroids and their treatment / E. Hrubosova // CeskaGynekol. – 2011. – Vol. 76 (2). – P. 152-157.156.Hyder, S.M. Regulation of vascular endothelial growth factor expressionby estrogens and progestins / S.M. Hyder, J.C. Huang, Z.
Nawaz et al. //Environmental. Health. Perspectives. – 2000. – Vol. 108 (5). – P. 785-790.116157.Ishikawa, H. Progesterone is essential for maintenance and growth ofuterine leiomyoma / H. Ishikawa, K. Ishi, V. Ann Serna, R. Kakazu et al. //Endocrinology. – 2010. – Vol. 151 (6). – P. 2433-2442.158.Ishwad, C.S. Two discrete regions of deletion at 7q in uterine leiomyomas /C.S. Ishwad, R.E. Ferrell, K. Hanley et al. // Genes, Chromosomes and Cancer. –1997. – Vol. 19.
– № 3. – P. 156-160.159.Jadaon, J.E. Prospective evaluation of early follicular ovarian stromalblood flow in infertile women undergoing IVF-ET treatment / J.E. Jadaon,M. Ben-Ami, S. Haddad, O. Radin et al. // Gynecol. Endocrinol. – 2012. – May. –Vol. 28 (5). – P. 356-359.160.Je, E.M. Mutational analysis of MED12 exon 2 in uterine leiomyoma andother common tumors / E.M. Je, M.R. Kim, K.O. Min, N.J. Yoo, S.H.
Lee // Int.J. Cancer. – 2012. – Sep. – Vol. 131 (6). – P. 1044-1047.161.Jokubkiene, L. Number of antral follicles, ovarian volume, and vascularindices in asymptomatic women 20 to 39 years old as assessed by 3-dimensionalsonography: a prospective cross-sectional study / L. Jokubkiene, P. Sladkevicius,L.
Valentin // J. Ultrasound. Med. – 2012. – Oct. – Vol. 31 (10). – P. 1635-1649.162.Jokubkiene, L. Ovarian size and vascularization as assessed by three-dimensional grayscale and power Doppler ultrasound in asymptomatic women20-39 yearsoldusingcombinedoralcontraceptives/L. Jokubkiene,P. Sladkevicius, L. Valentin // Contraception. – 2012.
– Sep. – Vol. 86 (3). –P. 257-267.163.Joseph, D.S. Myometrial cells undergo fibrotic transformation under theinfluence of transforming growth factor β-3 / D.S. Joseph, M. Malik,S. Nurudeen, W.H. Catherino // Fertility and Sterility. – 2010. – Vol. 93 (5). –P. 1500-1508.164.Kahn, V. Uterine artery embolization for myomas treatment / V. Kahn,J.P. Pelage, H. Marret // Presse.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
